A retrospective observational study of clinicopathological features of KRAS, NRAS, BRAF and PIK3CA mutations in Japanese patients with metastatic colorectal cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A retrospective observational study of clinicopathological features of KRAS, NRAS, BRAF and PIK3CA mutations in Japanese patients with metastatic colorectal cancer ; volume:15 ; number:1 ; day:11 ; month:4 ; year:2015 ; pages:1-9 ; date:12.2015
BMC cancer ; 15, Heft 1 (11.4.2015), 1-9, 12.2015
- Urheber
-
Kawazoe, Akihito
- Beteiligte Personen und Organisationen
-
Shitara, Kohei
Fukuoka, Shota
Kuboki, Yasutoshi
Bando, Hideaki
Okamoto, Wataru
Kojima, Takashi
Fuse, Nozomu
Yamanaka, Takeharu
Doi, Toshihiko
Ohtsu, Atsushi
Yoshino, Takayuki
SpringerLink (Online service)
- DOI
-
10.1186/s12885-015-1276-z
- URN
-
urn:nbn:de:1111-2016110614977
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
08.02.20252026, 14:58 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kawazoe, Akihito
- Shitara, Kohei
- Fukuoka, Shota
- Kuboki, Yasutoshi
- Bando, Hideaki
- Okamoto, Wataru
- Kojima, Takashi
- Fuse, Nozomu
- Yamanaka, Takeharu
- Doi, Toshihiko
- Ohtsu, Atsushi
- Yoshino, Takayuki
- SpringerLink (Online service)
Ähnliche Objekte (12)
Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study
Mutation status and prognostic values of KRAS, NRAS, BRAF and PIK3CA in 353 Chinese colorectal cancer patients
Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas
Prävalenz und Heterogenität von KRAS-, BRAF- und PIK3CA-Mutationen in Magenkarzinomen und ihren Metastasen
A phospho-proteomic study of cetuximab resistance in KRAS/NRAS/BRAF V600 wild-type colorectal cancer
Ameloblastic fibrosarcoma: clinicopathological and molecular analysis of seven cases highlighting frequent BRAF and occasional NRAS mutations
Prävalenz und Heterogenität von KRAS, BRAF und PIK3CA Mutationen in kolorektalen Adenokarzinomen und ihren korrespondierenden Metastasen
Detection of KRAS, NRAS and BRAF by mass spectrometry - a sensitive, reliable, fast and cost-effective technique
High resolution melting analysis of KRAS, BRAF and PIK3CA in KRASexon 2 wild-type metastatic colorectal cancer
Mutational profiles of different macroscopic subtypes of colorectal adenoma reveal distinct pathogenetic roles for KRAS, BRAF and PIK3CA
Significance of druggable targets (PD-L1, KRAS, BRAF, PIK3CA, MSI, and HPV) on curatively resected esophageal squamous cell carcinoma
BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: Primary or secondary genetic events in colorectal carcinogenesis?
Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study
Mutation status and prognostic values of KRAS, NRAS, BRAF and PIK3CA in 353 Chinese colorectal cancer patients
Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas
Prävalenz und Heterogenität von KRAS-, BRAF- und PIK3CA-Mutationen in Magenkarzinomen und ihren Metastasen
A phospho-proteomic study of cetuximab resistance in KRAS/NRAS/BRAF V600 wild-type colorectal cancer
Ameloblastic fibrosarcoma: clinicopathological and molecular analysis of seven cases highlighting frequent BRAF and occasional NRAS mutations
Prävalenz und Heterogenität von KRAS, BRAF und PIK3CA Mutationen in kolorektalen Adenokarzinomen und ihren korrespondierenden Metastasen
Detection of KRAS, NRAS and BRAF by mass spectrometry - a sensitive, reliable, fast and cost-effective technique
High resolution melting analysis of KRAS, BRAF and PIK3CA in KRASexon 2 wild-type metastatic colorectal cancer
Mutational profiles of different macroscopic subtypes of colorectal adenoma reveal distinct pathogenetic roles for KRAS, BRAF and PIK3CA
Significance of druggable targets (PD-L1, KRAS, BRAF, PIK3CA, MSI, and HPV) on curatively resected esophageal squamous cell carcinoma
BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: Primary or secondary genetic events in colorectal carcinogenesis?
Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study
Mutation status and prognostic values of KRAS, NRAS, BRAF and PIK3CA in 353 Chinese colorectal cancer patients
Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas
Prävalenz und Heterogenität von KRAS-, BRAF- und PIK3CA-Mutationen in Magenkarzinomen und ihren Metastasen
A phospho-proteomic study of cetuximab resistance in KRAS/NRAS/BRAF V600 wild-type colorectal cancer
Ameloblastic fibrosarcoma: clinicopathological and molecular analysis of seven cases highlighting frequent BRAF and occasional NRAS mutations
Prävalenz und Heterogenität von KRAS, BRAF und PIK3CA Mutationen in kolorektalen Adenokarzinomen und ihren korrespondierenden Metastasen
Detection of KRAS, NRAS and BRAF by mass spectrometry - a sensitive, reliable, fast and cost-effective technique
High resolution melting analysis of KRAS, BRAF and PIK3CA in KRASexon 2 wild-type metastatic colorectal cancer
Mutational profiles of different macroscopic subtypes of colorectal adenoma reveal distinct pathogenetic roles for KRAS, BRAF and PIK3CA
Significance of druggable targets (PD-L1, KRAS, BRAF, PIK3CA, MSI, and HPV) on curatively resected esophageal squamous cell carcinoma